Legend Biotech Corp Proceeds From Issue Of Ordinary Shares
Legend Biotech Corp (LEGN) reported Proceeds From Issue Of Ordinary Shares of $0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2023-03-30
| Period end | Proceeds From Issue Of Ordinary Shares 6 month | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|---|
| 2022-12-31 | $0.00 20-F · filed 2023-03-30 | |
| 2021-12-31 | $0.00 20-F · filed 2023-03-30 | |
| 2020-12-31 | $450.08M 20-F · filed 2023-03-30 | |
| 2020-06-30 | $450.08M 6-K · filed 2021-08-23 |